Related content

Phase II study of concurrent thoracic radiotherapy in combination with weekly paclitaxel plus carboplatin in locally advanced non-small cell lung cancer: LOGIK0401

By Takayama Koichi   Inoue Koji   Tokunaga Shoji   Matsumoto Takemasa   Oshima Tsukasa   Kawasaki Masayuki   Imanaga Tomotoshi   Kuba Mutsuo   Takeshita Masafumi   Harada Taishi   Shioyama Yoshiyuki   Nakanishi Yoichi  

Cancer Chemotherapy and Pharmacology, Vol. 72, Iss. 6, 2013-12 ,pp. : 1353-1359

Springer Publishing Company

Access to resources Recommend Favorite

The Efficacy of prophylactic Shakuyaku-Kanzo-to for myalgia and arthralgia following Carboplatin and Paclitaxel combination chemotherapy for non-small cell lung cancer

By Yoshida Tsutomu  

Supportive Care in Cancer, Vol. 17, Iss. 3, 2009-03 ,pp. : 315-320

Springer Publishing Company

Access to resources Recommend Favorite

Comparative analysis of carboplatin and paclitaxel combination chemotherapy schedules in previously untreated patients with advanced non-small cell lung cancer

By            

Oncology Letters, Vol. 5, Iss. 3, 2013-01 ,pp. : 761-767

Spandidos Publications

Access to resources Recommend Favorite

Phase II study of weekly chemotherapy with paclitaxel and gemcitabine as second-line treatment for advanced non-small cell lung cancer after treatment with platinum-based chemotherapy

By Mori Kiyoshi   Kamiyama Yukari   Kondo Tetsuro   Kano Yasuhiko   Kodama Tetsuro  

Cancer Chemotherapy and Pharmacology, Vol. 60, Iss. 2, 2007-07 ,pp. : 189-195

Springer Publishing Company

Access to resources Recommend Favorite

Phase II trial of a 2-h infusion of gemcitabine plus carboplatin as first-line chemotherapy for advanced non-small-cell lung cancer

By Xu N.   Shen P.   Zhang X.   Yu L.   Bao H.   Shi G.   Huang S.   Chen J.   Mou H.   Fang W.  

Cancer Chemotherapy and Pharmacology, Vol. 59, Iss. 1, 2007-01 ,pp. : 1-7

Springer Publishing Company

Access to resources Recommend Favorite